PMID: 2114179Jun 14, 1990Paper

Fatty acid metabolism in human lymphocytes. II. Activation of fatty acid desaturase-elongase systems during blastic transformation

Biochimica Et Biophysica Acta
A AnelA Piñeiro

Abstract

The fatty acid desaturation-elongation ability of human T-lymphocytes during blastic transformation was determined both by gas-liquid chromatography and incubation with radiolabeled precursors. Human peripheral blood mononuclear cells (PBMC) were activated with phytohemagglutinin (PHA) and cultured in media supplemented with different fatty acids (18:0, 18:1(n - 9), 18:2(n - 6), 18:3(n - 3) and 20:4(n - 6)) at a final concentration of 30 microM. All the fatty acids added were elongated by activated PBMC and the maximal activity was observed on 20:4(n - 6) (a 25% of conversion to 22:4(n - 6)). Supplementation with stearic acid increased the proportion of oleic (from 21.4% to 23.7%) and eicosaenoic (from 3.1% to 5.7%) acids in cellular lipids, indicating the existence of a delta 9-desaturase activity. Supplementation with linoleic and linoleic acids increased slightly the cell content in their more unsaturated derivatives. Direct measurement of desaturase activities was performed by incubating quiescent and activated PBMC with [1-14C]stearic, [1-14C]linoleic and [1-14C]linolenic acids. Quiescent cells exhibited a very low delta 9-desaturase and no sign of delta 6-desaturase activity. A moderate and progressive activation of delta...Continue Reading

References

Sep 19, 1975·Biochimica Et Biophysica Acta·E FerberK Resch
Mar 14, 1989·Biochimica Et Biophysica Acta·S E ShiresL K Trejdosiewicz
Aug 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·T M ButtkeJ A McCubrey
Jun 1, 1989·Archives of Biochemistry and Biophysics·M Garcia Zevallos, T Farkas
Nov 2, 1987·Biochimica Et Biophysica Acta·M Goppelt-Strübe, K Resch
Jan 1, 1988·Annual Review of Immunology·H CleversC Terhorst
Jan 1, 1987·Progress in Lipid Research·M D Rosenthal
Mar 1, 1986·Archives of Biochemistry and Biophysics·L PajorT Farkas
Mar 1, 1983·Biochimica Et Biophysica Acta·J C Chern, J E Kinsella
Feb 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·E G HillR T Holman
Jan 1, 1980·Progress in Lipid Research·A A SpectorB T Hyman
Jan 1, 1982·Medical & Biological Engineering & Computing·D B SattelleR E Holder

❮ Previous
Next ❯

Citations

Aug 1, 1994·Mechanisms of Ageing and Development·A R VanMeterL J Jenski
May 10, 2003·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·U S BabuR B Raybourne
Jun 10, 2005·Journal of Veterinary Medicine. A, Physiology, Pathology, Clinical Medicine·A SeidelH Fuhrmann
Jan 15, 1999·Prostaglandins, Leukotrienes, and Essential Fatty Acids·I MarzoJ Naval
Apr 1, 1994·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·P C CalderE A Newsholme
Nov 17, 1993·Biochemical Pharmacology·R M SánchezJ C Laguna
Apr 17, 2004·Journal of Veterinary Medicine. A, Physiology, Pathology, Clinical Medicine·J ThanasakK E Müller
Apr 20, 2000·JPEN. Journal of Parenteral and Enteral Nutrition·D GranatoG Dutot
Sep 1, 1991·AIDS Research and Human Retroviruses·J J AguilarJ Uriel
Oct 8, 2018·Journal of Lipid Research·Philippe-Pierre RobichaudMarc E Surette
Dec 28, 2018·The British Journal of Nutrition·Graham C Burdge
Oct 1, 1994·Cancer Immunology, Immunotherapy : CII·P PurasiriO Eremin
Jan 1, 1992·Progress in Lipid Research·D L CintiS K Suneja
Jun 4, 2021·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Arista NienaberLinda Malan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.